Galventa provides pharmaceutical manufacturing services for a micro-pellet-based food supplement that relieves sleep inertia symptoms.
Galventa has raised $1.8M in total funding. The most recent round was Seed. The last funding was announced in December 2023.
Galventa's investors include Venture Kick, Kickfund, Founders Factory, Innosuisse, Gen Ilac.
Galventa is headquartered in Saint Gallen, Switzerland.
Galventa provides pharmaceutical manufacturing services for a micro-pellet-based food supplement that relieves sleep inertia symptoms.
Galventa is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Galventa — Funding & Investors." VCBacked, December 31, 2023, https://www.vcbacked.co/company/galventa. Accessed July 20, 2026.
VCBacked. (2023). Galventa — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/galventa
{{cite web |title=Galventa — Funding & Investors |url=https://www.vcbacked.co/company/galventa |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated